Reduced glycogen availability is associated with increased AMPKalpha2 activity, nuclear AMPKalpha2 protein abundance, and GLUT4 mRNA expression in contracting human skeletal muscle.
Author Correction: Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activities.
Autorzy:
Pulito C; Molecular Chemoprevention Unit, Italian National Cancer Institute 'Regina Elena', Rome, Italy. Mori F; Molecular Chemoprevention Unit, Italian National Cancer Institute 'Regina Elena', Rome, Italy. Sacconi A; Oncogenomic and Epigenetic Unit, Italian National Cancer Institute 'Regina Elena', Rome, Italy. Goeman F; Oncogenomic and Epigenetic Unit, Italian National Cancer Institute 'Regina Elena', Rome, Italy. Ferraiuolo M; Molecular Chemoprevention Unit, Italian National Cancer Institute 'Regina Elena', Rome, Italy. Pasanisi P; Department of Preventive & Predictive Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy. Campagnoli C; Unit of Endocrinological Gynecology, Ospedale Sant'Anna di Torino, Turin, Italy. Berrino F; Department of Preventive & Predictive Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy. Fanciulli M; SAFU, 'Regina Elena' National Cancer Institute, Rome, Italy. Ford RJ; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, ON, Canada. Levrero M; Epigénétique et Épigénomique des Carcinomes Hépathocellulaires Viro-Induits du Centre de Recherche en Cancérologie de Lyon, Lyon, France. Pediconi N; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. Ciuffreda L; Division of Medical Oncology A, Italian National Cancer Institute 'Regina Elena', Rome, Italy. Milella M; Division of Medical Oncology A, Italian National Cancer Institute 'Regina Elena', Rome, Italy. SteinbergGR; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, ON, Canada. Cioce M; Oncogenomic and Epigenetic Unit, Italian National Cancer Institute 'Regina Elena', Rome, Italy. Muti P; Department of Oncology, Juravinski Cancer Center, McMaster University, Hamilton, ON, Canada. Strano S; Molecular Chemoprevention Unit, Italian National Cancer Institute 'Regina Elena', Rome, Italy. .; Department of Oncology, Juravinski Cancer Center, McMaster University, Hamilton, ON, Canada. . Blandino G; Oncogenomic and Epigenetic Unit, Italian National Cancer Institute 'Regina Elena', Rome, Italy. .; Department of Oncology, Juravinski Cancer Center, McMaster University, Hamilton, ON, Canada. .
Pokaż więcej
Źródło:
Cell discovery [Cell Discov] 2024 Mar 13; Vol. 10 (1), pp. 29. Date of Electronic Publication: 2024 Mar 13.
Restoration of the ER stress response protein TDAG51 in hepatocytes mitigates NAFLD in mice.
Autorzy:
Yousof TR; Division of Nephrology, Department of Medicine, The Research Institute of St. Joe's Hamilton and the Hamilton Centre for Kidney Research, McMaster University, Hamilton, Ontario, Canada. Bouchard CC; Division of Nephrology, Department of Medicine, The Research Institute of St. Joe's Hamilton and the Hamilton Centre for Kidney Research, McMaster University, Hamilton, Ontario, Canada. Alb M; Division of Nephrology, Department of Medicine, The Research Institute of St. Joe's Hamilton and the Hamilton Centre for Kidney Research, McMaster University, Hamilton, Ontario, Canada. Lynn EG; Division of Nephrology, Department of Medicine, The Research Institute of St. Joe's Hamilton and the Hamilton Centre for Kidney Research, McMaster University, Hamilton, Ontario, Canada. Lhoták S; Division of Nephrology, Department of Medicine, The Research Institute of St. Joe's Hamilton and the Hamilton Centre for Kidney Research, McMaster University, Hamilton, Ontario, Canada. Jiang H; Department of Pediatrics, School of Medicine, University of Colorado Health Sciences Center, Aurora, Colorado, USA. MacDonald M; Division of Nephrology, Department of Medicine, The Research Institute of St. Joe's Hamilton and the Hamilton Centre for Kidney Research, McMaster University, Hamilton, Ontario, Canada. Li H; Department of Pharmacology and Toxicology, University of Arizona, Tucson, Arizona, USA. Byun JH; Division of Nephrology, Department of Medicine, The Research Institute of St. Joe's Hamilton and the Hamilton Centre for Kidney Research, McMaster University, Hamilton, Ontario, Canada. Makda Y; Division of Nephrology, Department of Medicine, The Research Institute of St. Joe's Hamilton and the Hamilton Centre for Kidney Research, McMaster University, Hamilton, Ontario, Canada. Athanasopoulos M; Department of Biology, McMaster University, Hamilton, Ontario, Canada. Maclean KN; Department of Pediatrics, School of Medicine, University of Colorado Health Sciences Center, Aurora, Colorado, USA. Cherrington NJ; Department of Pharmacology and Toxicology, University of Arizona, Tucson, Arizona, USA. Naqvi A; Department of Pathology and Molecular Medicine, St. Joseph's Healthcare Hamilton, McMaster University, Hamilton, Ontario, Canada. Igdoura SA; Department of Biology, McMaster University, Hamilton, Ontario, Canada; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada. Krepinsky JC; Division of Nephrology, Department of Medicine, The Research Institute of St. Joe's Hamilton and the Hamilton Centre for Kidney Research, McMaster University, Hamilton, Ontario, Canada; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada. SteinbergGR; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada; Division of Endocrinology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Austin RC; Division of Nephrology, Department of Medicine, The Research Institute of St. Joe's Hamilton and the Hamilton Centre for Kidney Research, McMaster University, Hamilton, Ontario, Canada; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada. Electronic address: .
Prostate-Specific Membrane Antigen (PSMA) Expression Predicts Need for Early Treatment in Prostate Cancer Patients Managed with Active Surveillance.
Autorzy:
Ahmadi E; Department of Oncology, McMaster University, Hamilton, ON L8S 4L8, Canada.; Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada.; Center for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, ON L8S 4L8, Canada. Wang S; Department of Oncology, McMaster University, Hamilton, ON L8S 4L8, Canada.; Center for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, ON L8S 4L8, Canada. Gouran-Savadkoohi M; Department of Oncology, McMaster University, Hamilton, ON L8S 4L8, Canada. Douvi G; Department of Oncology, McMaster University, Hamilton, ON L8S 4L8, Canada. Isfahanian N; Department of Oncology, McMaster University, Hamilton, ON L8S 4L8, Canada. Tsakiridis N; Department of Health Sciences, Brock University, St. Catharines, ON L2S 3A1, Canada. Faught BE; Department of Health Sciences, Brock University, St. Catharines, ON L2S 3A1, Canada. Cutz JC; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada. Sur M; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada. Chawla S; Department of Laboratory Medicine, Niagara Health System, St. Catharines, ON L2S 0A9, Canada. Pond GR; Department of Oncology, McMaster University, Hamilton, ON L8S 4L8, Canada. SteinbergGR; Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada.; Center for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, ON L8S 4L8, Canada. Brown I; Department of Surgery, Niagara Health System, St. Catharines, ON L2S 0A9, Canada. Tsakiridis T; Department of Oncology, McMaster University, Hamilton, ON L8S 4L8, Canada.; Center for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, ON L8S 4L8, Canada.; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada.
Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non-small cell lung cancer (NSCLC) through inhibition of HIF-1α.
Autorzy:
Biziotis OD; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Canada.; Centre for Discovery in Cancer Research, McMaster University, Hamilton, Canada.; Department of Oncology, McMaster University, Hamilton, Canada. Tsakiridis EE; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Canada.; Department of Medicine, McMaster University, Hamilton, Canada. Ali A; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Canada.; Centre for Discovery in Cancer Research, McMaster University, Hamilton, Canada.; Department of Oncology, McMaster University, Hamilton, Canada. Ahmadi E; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Canada.; Centre for Discovery in Cancer Research, McMaster University, Hamilton, Canada.; Department of Oncology, McMaster University, Hamilton, Canada. Wu J; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Canada.; Department of Medicine, McMaster University, Hamilton, Canada. Wang S; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Canada.; Centre for Discovery in Cancer Research, McMaster University, Hamilton, Canada.; Department of Oncology, McMaster University, Hamilton, Canada. Mekhaeil B; Department of Oncology, McMaster University, Hamilton, Canada. Singh K; Centre for Discovery in Cancer Research, McMaster University, Hamilton, Canada.; Department of Oncology, McMaster University, Hamilton, Canada. Menjolian G; Radiotherapy Program, Juravinski Cancer Centre, Hamilton, Canada. Farrell T; Radiation Physics Program, Juravinski Cancer Centre, Hamilton, Canada. Abdulkarim B; Department of Oncology, McGill University, Montréal, Canada. Sur RK; Department of Oncology, McMaster University, Hamilton, Canada.; Division of Radiation Oncology, Juravinski Cancer Centre, Hamilton, Canada. Mesci A; Department of Oncology, McMaster University, Hamilton, Canada. Ellis P; Department of Oncology, McMaster University, Hamilton, Canada. Berg T; Centre for Discovery in Cancer Research, McMaster University, Hamilton, Canada.; Department of Oncology, McMaster University, Hamilton, Canada. Bramson JL; Department of Oncology, McMaster University, Hamilton, Canada.; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Canada.; Michael DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Canada. Muti P; Department of Oncology, McMaster University, Hamilton, Canada.; Department of Biomedical, Surgical and Dental Sciences, University of Milan, Italy. SteinbergGR; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Canada.; Department of Medicine, McMaster University, Hamilton, Canada.; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Canada. Tsakiridis T; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Canada.; Centre for Discovery in Cancer Research, McMaster University, Hamilton, Canada.; Department of Oncology, McMaster University, Hamilton, Canada.; Division of Radiation Oncology, Juravinski Cancer Centre, Hamilton, Canada.; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Canada.
Pokaż więcej
Źródło:
Molecular oncology [Mol Oncol] 2023 Nov; Vol. 17 (11), pp. 2235-2256. Date of Electronic Publication: 2023 Aug 27.
Macrophage AMPK β1 activation by PF-06409577 reduces the inflammatory response, cholesterol synthesis, and atherosclerosis in mice.
Autorzy:
Day EA; Centre for Metabolism, Obesity and Diabetes Research, Department of Medicine, McMaster University, Hamilton, ON, Canada.; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, ON, Canada. Townsend LK; Centre for Metabolism, Obesity and Diabetes Research, Department of Medicine, McMaster University, Hamilton, ON, Canada.; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, ON, Canada. Rehal S; Centre for Metabolism, Obesity and Diabetes Research, Department of Medicine, McMaster University, Hamilton, ON, Canada.; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, ON, Canada. Batchuluun B; Centre for Metabolism, Obesity and Diabetes Research, Department of Medicine, McMaster University, Hamilton, ON, Canada.; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, ON, Canada. Wang D; Centre for Metabolism, Obesity and Diabetes Research, Department of Medicine, McMaster University, Hamilton, ON, Canada.; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, ON, Canada. Morrow MR; Centre for Metabolism, Obesity and Diabetes Research, Department of Medicine, McMaster University, Hamilton, ON, Canada.; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, ON, Canada. Lu R; Centre for Metabolism, Obesity and Diabetes Research, Department of Medicine, McMaster University, Hamilton, ON, Canada.; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, ON, Canada. Lundenberg L; Centre for Metabolism, Obesity and Diabetes Research, Department of Medicine, McMaster University, Hamilton, ON, Canada.; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, ON, Canada. Lu JH; Centre for Metabolism, Obesity and Diabetes Research, Department of Medicine, McMaster University, Hamilton, ON, Canada.; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, ON, Canada. Desjardins EM; Centre for Metabolism, Obesity and Diabetes Research, Department of Medicine, McMaster University, Hamilton, ON, Canada.; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, ON, Canada. Smith TKT; Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, Centre for Infection, Immunity and Inflammation, Ottawa Institute of Systems Biology, Centre for Catalysis Research and Innovation, University of Ottawa, Ottawa, ON, Canada. Raphenya AR; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada. McArthur AG; Centre for Metabolism, Obesity and Diabetes Research, Department of Medicine, McMaster University, Hamilton, ON, Canada.; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada. Fullerton MD; Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, Centre for Infection, Immunity and Inflammation, Ottawa Institute of Systems Biology, Centre for Catalysis Research and Innovation, University of Ottawa, Ottawa, ON, Canada. SteinbergGR; Centre for Metabolism, Obesity and Diabetes Research, Department of Medicine, McMaster University, Hamilton, ON, Canada.; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, ON, Canada.; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada.
Pokaż więcej
Źródło:
IScience [iScience] 2023 Oct 20; Vol. 26 (11), pp. 108269. Date of Electronic Publication: 2023 Oct 20 (Print Publication: 2023).
Combination of an ACLY inhibitor with a GLP-1R agonist exerts additive benefits on nonalcoholic steatohepatitis and hepatic fibrosis in mice.
Autorzy:
Desjardins EM; Centre for Metabolism Obesity and Diabetes Research, McMaster University, Hamilton ON L8S 4L8, Canada; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada. Wu J; Centre for Metabolism Obesity and Diabetes Research, McMaster University, Hamilton ON L8S 4L8, Canada; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada; Population Health Research Institute, McMaster University, Hamilton, ON L8L 2X2, Canada. Lavoie DCT; Centre for Metabolism Obesity and Diabetes Research, McMaster University, Hamilton ON L8S 4L8, Canada; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada. Ahmadi E; Centre for Metabolism Obesity and Diabetes Research, McMaster University, Hamilton ON L8S 4L8, Canada; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada. Townsend LK; Centre for Metabolism Obesity and Diabetes Research, McMaster University, Hamilton ON L8S 4L8, Canada; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada. Morrow MR; Centre for Metabolism Obesity and Diabetes Research, McMaster University, Hamilton ON L8S 4L8, Canada; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada. Wang D; Centre for Metabolism Obesity and Diabetes Research, McMaster University, Hamilton ON L8S 4L8, Canada; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada. Tsakiridis EE; Centre for Metabolism Obesity and Diabetes Research, McMaster University, Hamilton ON L8S 4L8, Canada; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada. Batchuluun B; Centre for Metabolism Obesity and Diabetes Research, McMaster University, Hamilton ON L8S 4L8, Canada; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada. Fayyazi R; Centre for Metabolism Obesity and Diabetes Research, McMaster University, Hamilton ON L8S 4L8, Canada; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada. Kwiecien JM; Department of Pathology, McMaster University, Hamilton, ON L8S 4L8, Canada. Tsakiridis T; Centre for Metabolism Obesity and Diabetes Research, McMaster University, Hamilton ON L8S 4L8, Canada; Department of Oncology, McMaster University, Hamilton, ON L8S 4L8, Canada. Lally JSV; Centre for Metabolism Obesity and Diabetes Research, McMaster University, Hamilton ON L8S 4L8, Canada; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada. Paré G; Centre for Metabolism Obesity and Diabetes Research, McMaster University, Hamilton ON L8S 4L8, Canada; Population Health Research Institute, McMaster University, Hamilton, ON L8L 2X2, Canada; Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, ON L8L 2X2, Canada. Pinkosky SL; Esperion Therapeutics, Inc., Ann Arbor, MI, USA. SteinbergGR; Centre for Metabolism Obesity and Diabetes Research, McMaster University, Hamilton ON L8S 4L8, Canada; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON L8L 2X2, Canada. Electronic address: .
The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy.
Autorzy:
Ali A; Departments of Oncology, McMaster University, Hamilton, ON, Canada.; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, ON, Canada.; Centre for Discovery in Cancer Research, McMaster University, Hamilton, ON, Canada. Mekhaeil B; Departments of Oncology, McMaster University, Hamilton, ON, Canada. Biziotis OD; Departments of Oncology, McMaster University, Hamilton, ON, Canada.; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, ON, Canada.; Centre for Discovery in Cancer Research, McMaster University, Hamilton, ON, Canada. Tsakiridis EE; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, ON, Canada.; Departments of Medicine, McMaster University, Hamilton, ON, Canada. Ahmadi E; Departments of Oncology, McMaster University, Hamilton, ON, Canada.; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, ON, Canada. Wu J; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, ON, Canada.; Departments of Medicine, McMaster University, Hamilton, ON, Canada. Wang S; Departments of Oncology, McMaster University, Hamilton, ON, Canada.; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, ON, Canada.; Centre for Discovery in Cancer Research, McMaster University, Hamilton, ON, Canada. Singh K; Departments of Oncology, McMaster University, Hamilton, ON, Canada.; Centre for Discovery in Cancer Research, McMaster University, Hamilton, ON, Canada. Menjolian G; Department of Radiotherapy, Juravinski Cancer Center, Hamilton, ON, Canada. Farrell T; Department of Physics, Juravinski Cancer Center, Hamilton, Ontario, Canada. Mesci A; Departments of Oncology, McMaster University, Hamilton, ON, Canada.; Department of Radiation Oncology, Juravinski Cancer Center, Hamilton, ON, Canada. Liu S; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada. Berg T; Departments of Oncology, McMaster University, Hamilton, ON, Canada.; Centre for Discovery in Cancer Research, McMaster University, Hamilton, ON, Canada. Bramson JL; Departments of Oncology, McMaster University, Hamilton, ON, Canada.; Centre for Discovery in Cancer Research, McMaster University, Hamilton, ON, Canada.; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada. SteinbergGR; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, ON, Canada.; Departments of Medicine, McMaster University, Hamilton, ON, Canada.; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada. Tsakiridis T; Departments of Oncology, McMaster University, Hamilton, ON, Canada. .; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, ON, Canada. .; Centre for Discovery in Cancer Research, McMaster University, Hamilton, ON, Canada. .; Department of Radiation Oncology, Juravinski Cancer Center, Hamilton, ON, Canada. .; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2023 Sep 08; Vol. 6 (1), pp. 919. Date of Electronic Publication: 2023 Sep 08.
GDF15 promotes weight loss by enhancing energy expenditure in muscle.
Autorzy:
Wang D; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada.; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Townsend LK; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada.; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. DesOrmeaux GJ; Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada. Frangos SM; Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada. Batchuluun B; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada.; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Dumont L; Department of Pharmacology-Physiology, Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, Quebec, Canada. Kuhre RE; Global Obesity and Liver Disease Research, Global Drug Discovery, Novo Nordisk, Maaloev, Denmark.; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Ahmadi E; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada.; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Hu S; Key Laboratory of Geriatric Nutrition and Health, Ministry of Education, Beijing Technology and Business University, Beijing, China.; Shenzhen Key Laboratory of Metabolic Health, Center for Energy Metabolism and Reproduction, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China. Rebalka IA; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada. Gautam J; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada.; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Jabile MJT; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada.; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Pileggi CA; Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.; Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, Ontario, Canada. Rehal S; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada.; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Desjardins EM; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada.; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Tsakiridis EE; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada.; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Lally JSV; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada.; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Juracic ES; Department of Kinesiology and Health Sciences, University of Waterloo, Waterloo, Ontario, Canada. Tupling AR; Department of Kinesiology and Health Sciences, University of Waterloo, Waterloo, Ontario, Canada. Gerstein HC; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada.; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada. Paré G; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada.; Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada.; Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, Ontario, Canada.; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada. Tsakiridis T; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada.; Department of Oncology, McMaster University, Hamilton, Ontario, Canada. Harper ME; Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.; Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, Ontario, Canada. Hawke TJ; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada. Speakman JR; Shenzhen Key Laboratory of Metabolic Health, Center for Energy Metabolism and Reproduction, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.; State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.; School of Biological Sciences, University of Aberdeen, Aberdeen, UK.; CAS Center for Excellence in Animal Evolution and Genetics (CCEAEG), Kunming, China. Blondin DP; Department of Pharmacology-Physiology, Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, Quebec, Canada.; Division of Neurology, Department of Medicine, Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, Quebec, Canada. Holloway GP; Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada. Jørgensen SB; Global Obesity and Liver Disease Research, Global Drug Discovery, Novo Nordisk, Maaloev, Denmark.; Bio Innovation Hub Transformational Research Unit, Novo Nordisk, Boston, MA, USA. SteinbergGR; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada. .; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. .; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada. .
Pokaż więcej
Źródło:
Nature [Nature] 2023 Jul; Vol. 619 (7968), pp. 143-150. Date of Electronic Publication: 2023 Jun 28.
Author Correction: Chronic exposure to synthetic food colorant Allura Red AC promotes susceptibility to experimental colitis via intestinal serotonin in mice.
Autorzy:
Kwon YH; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.; Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada. Banskota S; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.; Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada. Wang H; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.; Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada. Rossi L; Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada.; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada. Grondin JA; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.; Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada. Syed SA; Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada.; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada.; Department of Medicine, McMaster University, Hamilton, ON, Canada. Yousefi Y; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.; Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada. Schertzer JD; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada.; Center for Metabolism, Obesity, and Diabetes Research, McMaster University, Hamilton, ON, Canada. Morrison KM; Center for Metabolism, Obesity, and Diabetes Research, McMaster University, Hamilton, ON, Canada.; Department of Pediatrics, McMaster University, Hamilton, ON, Canada. Wade MG; Environmental Health, Science and Research Bureau, Health Canada, Ottawa, ON, Canada. Holloway AC; Center for Metabolism, Obesity, and Diabetes Research, McMaster University, Hamilton, ON, Canada.; Department of Obstetrics and Gynecology, McMaster University, Hamilton, ON, Canada. Surette MG; Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada.; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada.; Department of Medicine, McMaster University, Hamilton, ON, Canada. SteinbergGR; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada.; Department of Medicine, McMaster University, Hamilton, ON, Canada.; Center for Metabolism, Obesity, and Diabetes Research, McMaster University, Hamilton, ON, Canada. Khan WI; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada. .; Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2023 May 30; Vol. 14 (1), pp. 3125. Date of Electronic Publication: 2023 May 30.
Inhibition of NADPH Oxidase (NOX) 2 Mitigates Colitis in Mice with Impaired Macrophage AMPK Function.
Autorzy:
Banskota S; Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON L8S 4L8, Canada.; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada. Wang H; Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON L8S 4L8, Canada.; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada. Kwon YH; Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON L8S 4L8, Canada.; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada. Gautam J; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, ON L8S 4L8, Canada.; Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada.; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada. Haq S; Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON L8S 4L8, Canada.; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada. Grondin J; Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON L8S 4L8, Canada.; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada. SteinbergGR; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, ON L8S 4L8, Canada.; Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada.; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada. Khan WI; Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON L8S 4L8, Canada.; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada.; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, ON L8S 4L8, Canada.
Pokaż więcej
Źródło:
Biomedicines [Biomedicines] 2023 May 14; Vol. 11 (5). Date of Electronic Publication: 2023 May 14.
Preclinical evaluation of tolvaptan and salsalate combination therapy in a Pkd1 -mouse model.
Autorzy:
Song X; Division of Nephrology, University Health Network and University of Toronto, Toronto, ON, Canada. Leonhard WN; Department of Human Genetics, Leiden University Medical Center, Leiden, Netherlands. Kanhai AA; Department of Human Genetics, Leiden University Medical Center, Leiden, Netherlands. SteinbergGR; Centre for Metabolism, Obesity and Diabetes Research, Department of Medicine, McMaster University, Hamilton, ON, Canada. Pei Y; Division of Nephrology, University Health Network and University of Toronto, Toronto, ON, Canada. Peters DJM; Department of Human Genetics, Leiden University Medical Center, Leiden, Netherlands.
Pokaż więcej
Źródło:
Frontiers in molecular biosciences [Front Mol Biosci] 2023 Jan 19; Vol. 10, pp. 1058825. Date of Electronic Publication: 2023 Jan 19 (Print Publication: 2023).
F-DCFPyL (PSMA) PET as a radiotherapy response assessment tool in metastatic prostate cancer.
Autorzy:
Mesci A; Radiation Oncology, Juravinski Cancer Centre, Hamilton Health Sciences, Ontario, Canada.; Dept. of Oncology, McMaster University, Hamilton, Ontario, Canada. Ahmadi E; Dept. of Oncology, McMaster University, Hamilton, Ontario, Canada.; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada. Ali A; Dept. of Oncology, McMaster University, Hamilton, Ontario, Canada.; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada. Gouran-Savadkoohi M; Radiation Oncology, Juravinski Cancer Centre, Hamilton Health Sciences, Ontario, Canada.; Dept. of Oncology, McMaster University, Hamilton, Ontario, Canada. Evelyn Tsakiridis E; Dept. of Medicine, McMaster University, Hamilton, Ontario, Canada.; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada. Biziotis OD; Dept. of Oncology, McMaster University, Hamilton, Ontario, Canada.; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada. Chow T; Physics, Juravinski Cancer Centre, Hamilton Health Sciences, Ontario, Canada. Kapoor A; Division of Urology, McMaster University and St. Joseph's Hospital, Hamilton, Ontario, Canada. Sur M; Dept. of Pathology, McMaster University, Hamilton, Ontario, Canada. SteinbergGR; Dept. of Medicine, McMaster University, Hamilton, Ontario, Canada.; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada. Liu S; Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. Zukotynski K; Dept. of Radiology, McMaster University, Hamilton, Ontario, Canada. Tsakiridis T; Radiation Oncology, Juravinski Cancer Centre, Hamilton Health Sciences, Ontario, Canada.; Dept. of Oncology, McMaster University, Hamilton, Ontario, Canada.; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada.
Blocking AMPK β1 myristoylation enhances AMPK activity and protects mice from high-fat diet-induced obesity and hepatic steatosis.
Autorzy:
Neopane K; Nestlé Institute of Health Sciences, Nestlé Research, Société des Produits Nestlé S.A., 1015 Lausanne, Switzerland; School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne 1015, Switzerland. Kozlov N; Protein Chemistry and Metabolism, St. Vincent's Institute of Medical Research, Melbourne, VIC 3065, Australia. Negoita F; Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen 2200, Denmark. Murray-Segal L; Protein Chemistry and Metabolism, St. Vincent's Institute of Medical Research, Melbourne, VIC 3065, Australia. Brink R; Garvan Institute of Medical Research and St. Vincent's Clinical School, University of New South Wales, Sydney, Darlinghurst, NSW 2010, Australia. Hoque A; Metabolic Signalling, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065, Australia. Ovens AJ; Metabolic Signalling, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065, Australia. Tjin G; Stem Cell Regulation, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065, Australia; Department of Medicine, University of Melbourne, Parkville, VIC 3010, Australia. McAloon LM; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Parkville, VIC 3052, Australia. Yu D; Protein Chemistry and Metabolism, St. Vincent's Institute of Medical Research, Melbourne, VIC 3065, Australia. Ling NXY; Metabolic Signalling, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065, Australia. Sanders MJ; Nestlé Institute of Health Sciences, Nestlé Research, Société des Produits Nestlé S.A., 1015 Lausanne, Switzerland. Oakhill JS; Metabolic Signalling, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065, Australia; Department of Medicine, University of Melbourne, Parkville, VIC 3010, Australia. Scott JW; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Parkville, VIC 3052, Australia; The Florey Institute of Neuroscience and Mental Health, Parkville, Melbourne, VIC 3052, Australia. SteinbergGR; Centre for Metabolism, Obesity, and Diabetes Research, Departments of Medicine and Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada. Loh K; Department of Medicine, University of Melbourne, Parkville, VIC 3010, Australia; Diabetes and Metabolic Disease, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065, Australia. Kemp BE; Protein Chemistry and Metabolism, St. Vincent's Institute of Medical Research, Melbourne, VIC 3065, Australia; Department of Medicine, University of Melbourne, Parkville, VIC 3010, Australia; Mary McKillop Institute for Health Research, Australian Catholic University, Melbourne 3000, VIC, Australia. Sakamoto K; Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen 2200, Denmark. Electronic address: . Galic S; Protein Chemistry and Metabolism, St. Vincent's Institute of Medical Research, Melbourne, VIC 3065, Australia; Department of Medicine, University of Melbourne, Parkville, VIC 3010, Australia. Electronic address: .
Pokaż więcej
Źródło:
Cell reports [Cell Rep] 2022 Dec 20; Vol. 41 (12), pp. 111862.
Chronic exposure to synthetic food colorant Allura Red AC promotes susceptibility to experimental colitis via intestinal serotonin in mice.
Autorzy:
Kwon YH; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.; Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada. Banskota S; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.; Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada. Wang H; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.; Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada. Rossi L; Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada.; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada. Grondin JA; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.; Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada. Syed SA; Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada.; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada.; Department of Medicine, McMaster University, Hamilton, ON, Canada. Yousefi Y; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.; Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada. Schertzer JD; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada.; Center for Metabolism, Obesity, and Diabetes Research, McMaster University, Hamilton, ON, Canada. Morrison KM; Center for Metabolism, Obesity, and Diabetes Research, McMaster University, Hamilton, ON, Canada.; Department of Pediatrics, McMaster University, Hamilton, ON, Canada. Wade MG; Environmental Health, Science and Research Bureau, Health Canada, Ottawa, ON, Canada. Holloway AC; Center for Metabolism, Obesity, and Diabetes Research, McMaster University, Hamilton, ON, Canada.; Department of Obstetrics and Gynecology, McMaster University, Hamilton, ON, Canada. Surette MG; Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada.; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada.; Department of Medicine, McMaster University, Hamilton, ON, Canada. SteinbergGR; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada.; Department of Medicine, McMaster University, Hamilton, ON, Canada.; Center for Metabolism, Obesity, and Diabetes Research, McMaster University, Hamilton, ON, Canada. Khan WI; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada. .; Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2022 Dec 20; Vol. 13 (1), pp. 7617. Date of Electronic Publication: 2022 Dec 20.
High-fructose feeding suppresses cold-stimulated brown adipose tissue glucose uptake independently of changes in thermogenesis and the gut microbiome.
Autorzy:
Richard G; Centre de recherche du Centre hospitalier universitaire de Sherbrooke, Sherbrooke, QC J1H 5H3, Canada; Department of Nuclear Medicine and Radiobiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC J1H 5H3, Canada. Blondin DP; Centre de recherche du Centre hospitalier universitaire de Sherbrooke, Sherbrooke, QC J1H 5H3, Canada; Department of Medicine, Division of Neurology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC J1H 5H3, Canada. Syed SA; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada. Rossi L; Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada. Fontes ME; Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada. Fortin M; Centre de recherche du Centre hospitalier universitaire de Sherbrooke, Sherbrooke, QC J1H 5H3, Canada. Phoenix S; Centre de recherche du Centre hospitalier universitaire de Sherbrooke, Sherbrooke, QC J1H 5H3, Canada; Department of Nuclear Medicine and Radiobiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC J1H 5H3, Canada. Frisch F; Centre de recherche du Centre hospitalier universitaire de Sherbrooke, Sherbrooke, QC J1H 5H3, Canada. Dubreuil S; Centre de recherche du Centre hospitalier universitaire de Sherbrooke, Sherbrooke, QC J1H 5H3, Canada. Guérin B; Centre de recherche du Centre hospitalier universitaire de Sherbrooke, Sherbrooke, QC J1H 5H3, Canada; Department of Nuclear Medicine and Radiobiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC J1H 5H3, Canada. Turcotte ÉE; Centre de recherche du Centre hospitalier universitaire de Sherbrooke, Sherbrooke, QC J1H 5H3, Canada; Department of Nuclear Medicine and Radiobiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC J1H 5H3, Canada. Lepage M; Centre de recherche du Centre hospitalier universitaire de Sherbrooke, Sherbrooke, QC J1H 5H3, Canada; Department of Nuclear Medicine and Radiobiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC J1H 5H3, Canada. Surette MG; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada; Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada; Centre for Metabolism, Obesity, and Diabetes Research, McMaster University, Hamilton, ON L8N 3Z5, Canada; Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON L8S 4L8, Canada. Schertzer JD; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada; Centre for Metabolism, Obesity, and Diabetes Research, McMaster University, Hamilton, ON L8N 3Z5, Canada; Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON L8S 4L8, Canada. SteinbergGR; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada; Centre for Metabolism, Obesity, and Diabetes Research, McMaster University, Hamilton, ON L8N 3Z5, Canada; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada. Morrison KM; Centre for Metabolism, Obesity, and Diabetes Research, McMaster University, Hamilton, ON L8N 3Z5, Canada; Department of Pediatrics, McMaster University, Hamilton, ON L8N 3Z5, Canada. Carpentier AC; Centre de recherche du Centre hospitalier universitaire de Sherbrooke, Sherbrooke, QC J1H 5H3, Canada; Department of Medicine, Division of Endocrinology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC J1H 5H3, Canada. Electronic address: .
Shared pathobiology identifies AMPK as a therapeutic target for obesity and autosomal dominant polycystic kidney disease.
Autorzy:
Iliuta IA; Division of Nephrology, Department of Medicine, University Health Network and University of Toronto, Toronto, ON, Canada. Song X; Division of Nephrology, Department of Medicine, University Health Network and University of Toronto, Toronto, ON, Canada. Pickel L; Translational Medicine Program, The Hospital for Sick Children, Toronto, ON, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada. Haghighi A; Division of Nephrology, Department of Medicine, University Health Network and University of Toronto, Toronto, ON, Canada.; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States. Retnakaran R; Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, ON, Canada. Scholey J; Division of Nephrology, Department of Medicine, University Health Network and University of Toronto, Toronto, ON, Canada. Sung HK; Translational Medicine Program, The Hospital for Sick Children, Toronto, ON, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada. SteinbergGR; Department of Medicine, Centre for Metabolism, Obesity, and Diabetes Research, McMaster University, Hamilton, ON, Canada. Pei Y; Division of Nephrology, Department of Medicine, University Health Network and University of Toronto, Toronto, ON, Canada.
Pokaż więcej
Źródło:
Frontiers in molecular biosciences [Front Mol Biosci] 2022 Aug 23; Vol. 9, pp. 962933. Date of Electronic Publication: 2022 Aug 23 (Print Publication: 2022).
Metformin-induced reductions in tumor growth involves modulation of the gut microbiome.
Autorzy:
Broadfield LA; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, ON, Canada; Department of Medicine, McMaster University, Hamilton, ON, Canada. Saigal A; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, ON, Canada. Szamosi JC; Farncombe Family Digestive Research Institute, McMaster University, Hamilton, ON, Canada; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada. Hammill JA; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada. Bezverbnaya K; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada. Wang D; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, ON, Canada; Department of Medicine, McMaster University, Hamilton, ON, Canada. Gautam J; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, ON, Canada; Department of Medicine, McMaster University, Hamilton, ON, Canada. Tsakiridis EE; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, ON, Canada; Department of Medicine, McMaster University, Hamilton, ON, Canada. Di Pastena F; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, ON, Canada; Department of Medicine, McMaster University, Hamilton, ON, Canada. McNicol J; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada. Wu J; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, ON, Canada; Department of Medicine, McMaster University, Hamilton, ON, Canada. Syed S; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, ON, Canada; Department of Medicine, McMaster University, Hamilton, ON, Canada; Farncombe Family Digestive Research Institute, McMaster University, Hamilton, ON, Canada. Lally JSV; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, ON, Canada; Department of Medicine, McMaster University, Hamilton, ON, Canada. Raphenya AR; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada. Blouin MJ; Segal Cancer Center, Lady Davis Institute for Medical Research, Jewish General Hospital; Gerald Bronfman Department of Oncology, McGill University, Montreal, Canada. Pollak M; Segal Cancer Center, Lady Davis Institute for Medical Research, Jewish General Hospital; Gerald Bronfman Department of Oncology, McGill University, Montreal, Canada. Sacconi A; Oncogenomic and Epigenetic Unit, Italian National Cancer Institute 'Regina Elena', Rome, Italy. Blandino G; Oncogenomic and Epigenetic Unit, Italian National Cancer Institute 'Regina Elena', Rome, Italy. McArthur AG; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, ON, Canada; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada. Schertzer JD; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, ON, Canada; Farncombe Family Digestive Research Institute, McMaster University, Hamilton, ON, Canada; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada. Surette MG; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, ON, Canada; Department of Medicine, McMaster University, Hamilton, ON, Canada; Farncombe Family Digestive Research Institute, McMaster University, Hamilton, ON, Canada; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada. Collins SM; Department of Medicine, McMaster University, Hamilton, ON, Canada; Farncombe Family Digestive Research Institute, McMaster University, Hamilton, ON, Canada. Bramson JL; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada. Muti P; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, ON, Canada; Department of Oncology, McMaster University, Hamilton, ON, Canada. Tsakiridis T; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, ON, Canada; Department of Oncology, McMaster University, Hamilton, ON, Canada. SteinbergGR; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, ON, Canada; Department of Medicine, McMaster University, Hamilton, ON, Canada; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada. Electronic address: .
Pokaż więcej
Źródło:
Molecular metabolism [Mol Metab] 2022 Jul; Vol. 61, pp. 101498. Date of Electronic Publication: 2022 Apr 20.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies